Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Healthy Extracts (HYEX) Change in Receivables (2016 - 2025)

Healthy Extracts' Change in Receivables history spans 11 years, with the latest figure at $119443.0 for Q4 2025.

  • For Q4 2025, Change in Receivables rose 1463.19% year-over-year to $119443.0; the TTM value through Dec 2025 reached $139703.0, up 818.75%, while the annual FY2025 figure was $139703.0, 818.75% up from the prior year.
  • Change in Receivables reached $119443.0 in Q4 2025 per HYEX's latest filing, up from $27284.0 in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $119443.0 in Q4 2025 to a low of -$78783.0 in Q4 2023.
  • Average Change in Receivables over 5 years is $6871.6, with a median of -$6030.5 recorded in 2023.
  • Peak YoY movement for Change in Receivables: crashed 1663.78% in 2023, then skyrocketed 1463.19% in 2025.
  • A 5-year view of Change in Receivables shows it stood at $49755.0 in 2021, then tumbled by 89.87% to $5038.0 in 2022, then plummeted by 1663.78% to -$78783.0 in 2023, then soared by 88.88% to -$8762.0 in 2024, then surged by 1463.19% to $119443.0 in 2025.
  • Per Business Quant, the three most recent readings for HYEX's Change in Receivables are $119443.0 (Q4 2025), $27284.0 (Q3 2025), and -$66001.0 (Q2 2025).